Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma: author reply

Pathology. 2017 Aug;49(5):562-563. doi: 10.1016/j.pathol.2017.04.007. Epub 2017 Jun 28.

Authors

Jen-Fan Hang¹, Chin-Chen Pan²

Affiliations

¹ Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, and School of Medicine, National Yang-Ming University, Taipei, Taiwan.
² Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, and School of Medicine, National Yang-Ming University, Taipei, Taiwan. Electronic address: [email protected].

PMID: 28666644
DOI: 10.1016/j.pathol.2017.04.007

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma / genetics*
Colorectal Neoplasms / genetics
Humans
Mutation
Proto-Oncogene Proteins B-raf / genetics
Urinary Bladder Neoplasms / genetics*

Substances

Proto-Oncogene Proteins B-raf

Supplementary concepts

Urachal adenocarcinoma